An investigational, novel combination therapy, consisting of an N-methyl-D-aspartate receptor-modulating drug (ketamine) delivered intravenously (IV) in combination with manualized relapse prevention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback